CETP inhibitors
Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TAYLOR GAYLE E SMITH CAMERON J THOMPSON CHRISTOPHER F ALI AMJAD HUNT JULIANNE A SINCLAIR PETER J CHEN LIYA QURAISHI NAZIA KALLASHI FLORIDA KOWALCHICK JENNIFER KIM DOOSEOP SWEIS RAMZI F |
description | Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8334290B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8334290B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8334290B23</originalsourceid><addsrcrecordid>eNrjZOB3dg0JUMjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWxsYmRpYGTkbGRCgBACgdHkk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CETP inhibitors</title><source>esp@cenet</source><creator>TAYLOR GAYLE E ; SMITH CAMERON J ; THOMPSON CHRISTOPHER F ; ALI AMJAD ; HUNT JULIANNE A ; SINCLAIR PETER J ; CHEN LIYA ; QURAISHI NAZIA ; KALLASHI FLORIDA ; KOWALCHICK JENNIFER ; KIM DOOSEOP ; SWEIS RAMZI F</creator><creatorcontrib>TAYLOR GAYLE E ; SMITH CAMERON J ; THOMPSON CHRISTOPHER F ; ALI AMJAD ; HUNT JULIANNE A ; SINCLAIR PETER J ; CHEN LIYA ; QURAISHI NAZIA ; KALLASHI FLORIDA ; KOWALCHICK JENNIFER ; KIM DOOSEOP ; SWEIS RAMZI F</creatorcontrib><description>Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121218&DB=EPODOC&CC=US&NR=8334290B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121218&DB=EPODOC&CC=US&NR=8334290B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAYLOR GAYLE E</creatorcontrib><creatorcontrib>SMITH CAMERON J</creatorcontrib><creatorcontrib>THOMPSON CHRISTOPHER F</creatorcontrib><creatorcontrib>ALI AMJAD</creatorcontrib><creatorcontrib>HUNT JULIANNE A</creatorcontrib><creatorcontrib>SINCLAIR PETER J</creatorcontrib><creatorcontrib>CHEN LIYA</creatorcontrib><creatorcontrib>QURAISHI NAZIA</creatorcontrib><creatorcontrib>KALLASHI FLORIDA</creatorcontrib><creatorcontrib>KOWALCHICK JENNIFER</creatorcontrib><creatorcontrib>KIM DOOSEOP</creatorcontrib><creatorcontrib>SWEIS RAMZI F</creatorcontrib><title>CETP inhibitors</title><description>Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOB3dg0JUMjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWxsYmRpYGTkbGRCgBACgdHkk</recordid><startdate>20121218</startdate><enddate>20121218</enddate><creator>TAYLOR GAYLE E</creator><creator>SMITH CAMERON J</creator><creator>THOMPSON CHRISTOPHER F</creator><creator>ALI AMJAD</creator><creator>HUNT JULIANNE A</creator><creator>SINCLAIR PETER J</creator><creator>CHEN LIYA</creator><creator>QURAISHI NAZIA</creator><creator>KALLASHI FLORIDA</creator><creator>KOWALCHICK JENNIFER</creator><creator>KIM DOOSEOP</creator><creator>SWEIS RAMZI F</creator><scope>EVB</scope></search><sort><creationdate>20121218</creationdate><title>CETP inhibitors</title><author>TAYLOR GAYLE E ; SMITH CAMERON J ; THOMPSON CHRISTOPHER F ; ALI AMJAD ; HUNT JULIANNE A ; SINCLAIR PETER J ; CHEN LIYA ; QURAISHI NAZIA ; KALLASHI FLORIDA ; KOWALCHICK JENNIFER ; KIM DOOSEOP ; SWEIS RAMZI F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8334290B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>TAYLOR GAYLE E</creatorcontrib><creatorcontrib>SMITH CAMERON J</creatorcontrib><creatorcontrib>THOMPSON CHRISTOPHER F</creatorcontrib><creatorcontrib>ALI AMJAD</creatorcontrib><creatorcontrib>HUNT JULIANNE A</creatorcontrib><creatorcontrib>SINCLAIR PETER J</creatorcontrib><creatorcontrib>CHEN LIYA</creatorcontrib><creatorcontrib>QURAISHI NAZIA</creatorcontrib><creatorcontrib>KALLASHI FLORIDA</creatorcontrib><creatorcontrib>KOWALCHICK JENNIFER</creatorcontrib><creatorcontrib>KIM DOOSEOP</creatorcontrib><creatorcontrib>SWEIS RAMZI F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAYLOR GAYLE E</au><au>SMITH CAMERON J</au><au>THOMPSON CHRISTOPHER F</au><au>ALI AMJAD</au><au>HUNT JULIANNE A</au><au>SINCLAIR PETER J</au><au>CHEN LIYA</au><au>QURAISHI NAZIA</au><au>KALLASHI FLORIDA</au><au>KOWALCHICK JENNIFER</au><au>KIM DOOSEOP</au><au>SWEIS RAMZI F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CETP inhibitors</title><date>2012-12-18</date><risdate>2012</risdate><abstract>Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US8334290B2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | CETP inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A58%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAYLOR%20GAYLE%20E&rft.date=2012-12-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8334290B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |